Novare Surgical Systems Inc.

Gina is a Managing Partner and founder of Point Judith Capital Partners,. an early-stage venture capital firm in Providence, RI. Point Judith Capital invests in high-growth companies in the technology and health care industries. The firm focuses its investment activity in New England. Before joining Point Judith, Gina was the Senior Vice President of Fund Development at Village Ventures, Inc., a financial services firm focused on venture capital investments. In that role she managed the team that established sixteen venture capital funds around the country and raised over $250MM of capital across the network of funds. As part of the founding team at Village Ventures, she was involved in all aspects of the company's operations and strategy development.

Brent Ahrens joined the firm in 1999 and focuses on investments in healthcare companies. He actively assists portfolio companies in evaluating new products strategies, financing approaches, business development opportunities and intellectual property enhancement. Brent's past and present company involvement includes Cerexa (FRX), Coapt Systems, CoAxia, DexCom (DXCM), Novare Surgical, Pavad Medical, Peninsula Pharmaceuticals (JNJ), Relievant Medsystems, Revivant (ZOLL) and Transoma Medical. His particular interests are in the areas of implantable sensors and devices, infectious diseases, and CNS disorders. Prior to joining Canaan, Brent worked for General Surgical Innovations and Ethicon Endo-Surgery (Johnson & Johnson) in a variety of sales, marketing, business development and technical roles. In addition, he worked for IAP Research, a developer of technologies for defense and industrial applications. Brent holds a BS and MS in Mechanical Engineering from the University of Dayton and an MBA from the Tuck School of Business at Dartmouth College. He is also a Professional Engineer with a number of patents related to medical technologies. Brent is also an alumni of the Kauffman Fellows Program. Recently, Brent was included in the 2006 Midas List, a prominent venture capital listing which ranks the best dealmakers in high-tech and life sciences.

Roderick (Rod) Young is an experienced medical industry executive, having served as President and CEO of five medical companies since 1987. A mix of both medical device and pharmaceutical endeavors, these companies include Diasonics, Toshiba America MRI, Focus Surgery, General Surgical Innovations, Vivant Medical, and Targesome, Inc.